 cyclophosphamid cardiotox bone marrow transplant prospect evalu new regimen cyclophosphamid CY cardiotox lethal complic bone marrow transplant previou echocardiograph studi ventricular dysfunct due CY occur patient transplant cardiotox new protocol CY bone marrow transplant patient serial ecg echocardiogram twenty-six patient once-daili lower-dos protocol mean total mg/kg patient twice-daili higher-dos mean total mg/kg CY regimen higher-dos CY group signific reduct sum ecg voltag left ventricular mass index lvmi first week therapi chang third week CY chang lower-dos group ventricular eject fraction EF group patient clinic cardiotox pericard congest heart failur patient higher-dos group prior histori congest heart failur baselin EF independ correl clinic cardiotox dose-depend cardiotox use CY bone marrow transplant evid revers decreas ecg voltag increas left ventricular mass myocardi edema hemorrhag systol dysfunct common new regimen studi high-dos once-daili CY